(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Pledge of Certain Shares Held by Controlling Shareholder
Filed with SSE · Stock code 603439 · · 3 pages · Chinese
Summary by 6ix AI
GuiZhou SanLi Pharmaceutical Co., Ltd. announced the release and re-pledge of shares held by its controlling shareholder, Zhang Hai.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
GuiZhou SanLi Pharmaceutical Co., Ltd. on 6ix
Story so far
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report
- Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan
Earlier from GuiZhou SanLi Pharmaceutical
- Announcement on Abnormal Fluctuations in Stock Trading
- Semi-annual Report for 2026
- Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report
- Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan
- Announcement on Expected Decrease in Semi-annual Performance for 2026
Follow GuiZhou SanLi Pharmaceutical into a list and get an email when it puts out news.
Follow GuiZhou SanLi Pharmaceutical